• D-Mannitol: Identity, Mechanism, and Evidence Limits

  2026-10-16

  APExBIO identifies D-Mannitol (SKU B2090) as a 98% biochemical reagent associated with osmotic regulation research, renal function studies, and diuretic mechanism investigation. The product information supports a physicochemical and conceptual overview, but provides no identity-matched study, quantitative outcome, comparator, defined model, or product-specific biological validation. Its descriptions as an osmotic diuretic agent and weak renal vasodilator should therefore remain catalog-level claims rather than conclusions about efficacy or clinical applicability.

• Cy5 Maleimide: Identity, Mechanism, and Scope

  2026-10-16

  APExBIO’s product description identifies A8139 as non-sulfonated Cy5 maleimide, a thiol-reactive fluorescent dye for conceptual protein-labeling applications. Its reported chemistry and optical properties support interpretation as a fluorescent probe for biomolecule conjugation, but no identity-matched study establishes labeling performance, selectivity in particular proteins, or quantitative imaging outcomes.

• DAF-2 Diacetate: Documented Mechanism and Scope

  2026-10-15

  DAF-2 diacetate, also known as 4,5-Diaminofluorescein diacetate, is described by APExBIO as a cell-permeable fluorescent probe for nitric oxide detection. The product record supports a mechanistic interpretation in which intracellular esterase activity generates a less-permeable DAF-2 form that reacts with nitric oxide in the presence of oxygen to produce a fluorescent triazole signal. However, the available evidence is product-level rather than identity-matched research evidence: it does not establish assay performance, quantitative accuracy, effect sizes, selectivity, or outcomes in particular biological models.

• Alcian Blue & Nuclear Fast Red: Evidence Scope

  2026-10-15

  APExBIO describes the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 (K1188) as a dual-stain research reagent for visualizing acidic mucosubstances alongside cell nuclei. Its documented chemistry supports interpretation of a blue acid-mucus-associated signal with red nuclear contrast, but no identity-matched research paper, performance comparison, outcome statistic, or independent validation is available here.

• GLP-1 (9-36) Amide: Evidence and Scope

  2026-10-14

  GLP-1 (9-36) amide is presented by APExBIO as a peptide antagonist of the human GLP-1 receptor for research into receptor signaling and metabolic biology. The product description supports a conceptual role in distinguishing receptor-dependent effects from downstream assay observations, but it does not provide affinity, selectivity, quantitative antagonism, or identity-matched study outcomes. Accordingly, its documented scope is narrower than claims of validated performance in specific assays or disease models.

• Annexin V-FITC/PI Assay: Evidence Scope

  2026-10-14

  The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003), supplied by APExBIO, is described as a research-use fluorescence assay for distinguishing cell populations based on phosphatidylserine exposure and membrane integrity. No matched research paper was available, so conclusions are limited to the product’s documented identity and conceptual scope.

• BmTyr Proximity Labeling in Primary T Cells

  2026-10-13

  A 2026 study describes a biotin-free, click-compatible BmTyr platform for mapping nearby proteins in primary T cells. Its reported findings support feasibility in a difficult cellular context, including validation of TNFα pathway components and a proposed chromatin-associated localization for NKAP. The study does not establish that the platform broadly outperforms existing methods, and its chemistry is conceptually distinct from biotin-dependent detection reagents such as Streptavidin-HyperFluor 647.

• Sulfur, Reactive Nitrogen, and Nodule Senescence

  2026-10-13

  A 2025 Nature Communications study links sulfur delivery to soybean nodule symbiosomes with glutathione status, reactive nitrogen species control, and delayed senescence. DAF-2 diacetate provides relevant conceptual context for nitric oxide research, but the supplied study does not document use of this probe, and its findings should not be treated as evidence for a specific imaging workflow or direct agricultural intervention.

• Cy5 Maleimide: Identity and Evidence Scope

  2026-10-12

  The available evidence is limited to a supplier product description. It identifies Cy5 maleimide (non-sulfonated) as a cyanine fluorophore marketed for thiol-directed labeling of peptides and proteins, especially cysteine-containing biomolecules. The information supports a conceptual role in fluorescent biomolecule conjugation, but no independent paper was matched, so performance, selectivity in complex samples, biological outcomes, and comparative advantages remain unestablished.

• What the Evidence Shows—and Leaves Unresolved

  2026-10-11

  The supplied mouse study supports a disease-model finding for a specialized CRISPR lipid nanoparticle, but it does not validate EZ Cap Cy5 Firefly Luciferase mRNA, 5-moUTP modified mRNA, or the product’s imaging claims. The main evidence gaps concern cargo comparability, reporter interpretation, formulation attribution, and translation beyond the animal model.

• Biodegradable Polyesters for VEGF mRNA Delivery

  2026-10-10

  The reference study reports a three-armed biodegradable polyester platform designed to combine mRNA-complexing capacity with degradability and tissue-supportive bioactivity. In a critical limb ischemia model, arginine-functionalized particles carrying VEGF mRNA were reported to improve transfection, reduce oxidative stress, release nitric oxide, and promote angiogenesis, although the findings remain preclinical and require validation beyond the supplied journal pre-proof record.

• CD147+ sEVs and HCC Angiogenesis via PI3K/Akt

  2026-10-09

  Huang et al. identify CD147-positive small extracellular vesicles as a candidate circulating marker of hepatocellular carcinoma and provide mechanistic evidence linking these vesicles to endothelial angiogenesis through PI3K/Akt signaling. The study connects clinical sample analysis with cell-based and in vivo angiogenesis models, while also highlighting the need for independent diagnostic validation and pathway-specific follow-up.

• Annexin V-FITC/PI Apoptosis Assay Kit Overview

  2026-10-09

  A concise, product-focused overview of APExBIO’s K2003 Annexin V-FITC/PI Apoptosis Assay Kit, including its documented fluorescence readouts, conceptual scope, and evidence limitations.

• Brain–Spinal Circuits Control Mechanical Allodynia

  2026-10-08

  Huo et al. identify a contralateral pathway linking lPBN Oprm1 neurons, hypothalamic Pdyn neurons, and the spinal dorsal horn to the laterality and persistence of mechanical allodynia in mice. The findings provide a circuit-level explanation for why some peripheral insults produce bilateral, long-lasting hypersensitivity, while also defining important limits for translation beyond the tested models.

• Annexin V-FITC/PI Assay Kit Overview

  2026-10-08

  Supplier-described identity and conceptual scope of the Annexin V-FITC/PI Apoptosis Assay Kit, SKU K2003. No matched paper evidence was available, so product performance and broader applicability remain unverified.

627 records 1/42 page Next 12345 下5页 Last page